Valuation: DIAGNOS Inc.

Market Cap 32.51M 22.89M 20.01M 18.39M 17.14M 2.18B 33M 221M 85.82M 1.07B 85.92M 84.07M 3.69B P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 31.99M 22.52M 19.69M 18.09M 16.86M 2.14B 32.47M 217M 84.44M 1.05B 84.53M 82.72M 3.63B EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
88.96%
Yield 2025 *
-
Yield 2026 -
1 day+5.88%
1 week+14.89%
Current month+8.00%
1 month+20.00%
3 months-1.82%
6 months-25.00%
Current year-28.00%
1 week 0.23
Extreme 0.23
0.27
1 month 0.18
Extreme 0.185
0.27
Current year 0.18
Extreme 0.175
0.38
1 year 0.18
Extreme 0.175
0.42
3 years 0.18
Extreme 0.175
0.59
5 years 0.12
Extreme 0.125
0.6
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/05/2008
Chief Operating Officer - 16/01/2024
Director TitleAgeSince
Director/Board Member - 21/09/2000
Chairman 69 30/10/2025
Director/Board Member 72 28/09/2020
Date Insider Type Main position Quantity % Market Cap.
06-11Option

Chairman

300,000 0.2491%
06-11Option

Chief Financial Officer

200,000 0.1661%
06-11Option

Director

250,000 0.2076%
Change 5-day change 1-year change 3-year change Capi.($)
+5.88%+14.89%+25.58%-31.65% 22.89M
+1.14%+6.59%-0.84%+116.59% 272B
-0.40%+4.49%+17.45%+46.99% 90.17B
+4.74%+6.49%-54.93%-55.83% 84.05B
+1.23%-0.06%-38.78%-36.73% 79.55B
-0.81%-1.23%-40.14%-9.92% 54.92B
+0.61%+0.58%-36.17%-22.15% 44.51B
-0.54%+3.97%-3.73%+81.25% 35.78B
-0.76%+9.83%+5.87%+196.57% 34.28B
+5.65%+3.48%-34.01%-4.33% 32.37B
Average +1.67%+6.73%-15.97%+28.08% 72.78B
Weighted average by Cap. +1.22%+8.14%-15.40%+49.91%

Financials

2025 2026
Net sales 104K 73.08K 63.88K 58.71K 54.72K 6.96M 105K 705K 274K 3.42M 274K 268K 11.79M 65.48K 46.1K 40.3K 37.04K 34.52K 4.39M 66.47K 445K 173K 2.16M 173K 169K 7.43M
Net income -4.29M -3.02M -2.64M -2.42M -2.26M -287M -4.35M -29.11M -11.32M -141M -11.33M -11.08M -487M -4.56M -3.21M -2.8M -2.58M -2.4M -305M -4.62M -30.93M -12.02M -150M -12.04M -11.78M -517M
Net Debt -164K -115K -101K -92.6K -86.31K -10.97M -166K -1.11M -432K -5.39M -433K -423K -18.59M -525K -370K -323K -297K -277K -35.2M -533K -3.57M -1.39M -17.3M -1.39M -1.36M -59.63M
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
03/07/26 CA$0.2700 +5.88% 76,500
02/07/26 CA$0.2550 +2.00% 102,400
30/06/26 CA$0.2500 +4.17% 132,550
29/06/26 CA$0.2400 +2.13% 171,500
26/06/26 CA$0.2350 +4.44% 150,500

Annual profits - Rate of surprise